Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can we measure serum thyroglobulin?

P M Clark1, G Beckett

  • 1Department Of Clinical Biochemistry, University Hospital Birmingham NHS Trust, UK. pmclarkuhb@compuserve.com

Annals of Clinical Biochemistry
|June 1, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A survey on awareness, knowledge, and attitudes toward epilepsy in an urban community in Turkey.

Nigerian journal of clinical practice·2018
Same author

Novel and Haplotype Specific MicroRNAs Encoded by the Major Histocompatibility Complex.

Scientific reports·2018
Same author

The dichotomy between disease phenotype databases and the implications for understanding complex diseases involving the major histocompatibility complex.

International journal of immunogenetics·2015
Same author

A public health approach to musculoskeletal health.

Best practice & research. Clinical rheumatology·2014
Same author

Prognostic significance of thyroglobulin antibody epitopes in differentiated thyroid cancer.

The Journal of clinical endocrinology and metabolism·2014
Same author

Sedation and analgesia in intensive care: a comparison of fentanyl and remifentanil.

Pain research and treatment·2011
Same journal

Limitations of spectrophotometry in the analysis of cerebrospinal fluid bilirubin.

Annals of clinical biochemistry·2026
Same journal

Commentary on the impact of lithium heparin vacutainer tubes on daily cerebrospinal fluid analysis.

Annals of clinical biochemistry·2026
Same journal

Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

Annals of clinical biochemistry·2026
Same journal

From interpretable NT-proBNP prediction to equitable laboratory stewardship.

Annals of clinical biochemistry·2026
Same journal

Serum Sclerostin Levels in Children with Osteogenesis Imperfecta.

Annals of clinical biochemistry·2026
Same journal

Population-Specific HOMA-IR Reference Ranges in Iraq: Defining Insulin Sensitivity in a Middle Eastern Cohort.

Annals of clinical biochemistry·2026
See all related articles

Serum thyroglobulin (Tg) immunoassays monitor differentiated thyroid cancer treatment. Understanding Tg biochemistry and assay limitations, including thyroglobulin antibodies (TgAb), is crucial for accurate monitoring.

Area of Science:

  • Clinical chemistry
  • Endocrinology
  • Cancer biomarker analysis

Background:

  • Serum thyroglobulin (Tg) is a key tumor marker for differentiated thyroid cancer (DTC) management.
  • Immunoassays are the standard method for measuring serum Tg levels.
  • Accurate Tg measurement is essential for monitoring treatment response and detecting recurrence.

Purpose of the Study:

  • To review the analytical challenges in serum thyroglobulin (Tg) immunoassay.
  • To highlight the impact of thyroglobulin antibodies (TgAb) on Tg measurement accuracy.
  • To inform clinicians about the limitations of Tg immunoassays in thyroid cancer monitoring.

Main Methods:

  • Review of analytical issues pertinent to Tg immunoassays.
  • Discussion of factors affecting assay performance, including standardization and stability.

Related Experiment Videos

  • Analysis of TgAb interference and methods to assess it.

    • Main Results:

    • Key analytical issues include standardization, assay stability, detection limits, and working range.
    • Endogenous thyroglobulin antibodies (TgAb) significantly interfere with Tg measurements.
    • Current methods for assessing TgAb interference have notable limitations.

    Conclusions:

    • Accurate monitoring of differentiated thyroid cancer relies on understanding Tg immunoassay characteristics.
    • Clinicians must be aware of TgAb interference and assay limitations for reliable tumor marker interpretation.
    • Further improvements in Tg assay standardization and TgAb interference assessment are needed.